Release Date: 04/04/16 11:49 Summary: Notice of Mar 2016 Quarter Results & Teleconference-PSA.AX Price Sensitive: No Download Document 14.28KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%